Evidence Library

WuXi AppTec: peptide manufacturing capacity

The company disclosure describes SPPS capacity and expansion plans. Distinguish capacity reported at a stated date from a future target.

Companies, institutions and data are cited as public industry context. These references do not imply partnership, endorsement, certification or a commercial relationship with our company.

What the source covers

The company disclosure describes SPPS capacity and expansion plans. Distinguish capacity reported at a stated date from a future target.

Keep the scope clear

These independent sources do not establish a partnership with BLOPEP, certification of our products or approval of a particular batch. Follow the primary document for details and limitations.

Sources and verification scope

Corporate disclosure · S08

WuXi AppTec expands global manufacturing capacity ↗

WuXi AppTec

Source details (original language)

Scope: Corporate statement: >100,000 L at end of 2025; expansion toward 130,000 L
Document section: SPPS reactor volume paragraph
Limitations: WuXi AppTec capacity only; target is not installed capacity. Not WuXi Biologics or Bolang.
Claim verification date: 2026-09-09